BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18508374)

  • 1. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients.
    Israeli M; Klein T; Sredni B; Avitzur Y; Mor E; Bar-Nathen N; Steinberg R; Dinari G; Shapiro R
    Liver Transpl; 2008 Jun; 14(6):893-8. PubMed ID: 18508374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.
    Israeli M; Ben-Gal T; Yaari V; Valdman A; Matz I; Medalion B; Battler A; Sredni B; Kristt D; Klein T
    Transplantation; 2010 Apr; 89(8):968-76. PubMed ID: 20075792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform.
    Israeli M; Yussim A; Mor E; Sredni B; Klein T
    Transpl Immunol; 2007 Jul; 18(1):7-12. PubMed ID: 17584596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.
    Schulz-Juergensen S; Burdelski MM; Oellerich M; Brandhorst G
    Ther Drug Monit; 2012 Feb; 34(1):4-10. PubMed ID: 22210096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
    Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
    J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing pediatric immune response zones using the Cylex ImmuKnow assay.
    Hooper E; Hawkins DM; Kowalski RJ; Post DR; Britz JA; Brooks KC; Turman MA
    Clin Transplant; 2005 Dec; 19(6):834-9. PubMed ID: 16313333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the immune function assay in pediatric living donor liver transplantation.
    Fukuda A; Imadome K; Sakamoto S; Shigeta T; Uchida H; Matsunami M; Sasaki K; Kanazawa H; Kawano F; Nakazawa A; Fujiwara S; Kasahara M
    Pediatr Transplant; 2015 Mar; 19(2):144-52. PubMed ID: 25418834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT.
    Gesundheit B; Budowski E; Israeli M; Shapira MY; Resnick IB; Bringer R; Azar Y; Samuel S; Dray L; Amar A; Kristt D; Or R
    Bone Marrow Transplant; 2010 Mar; 45(3):527-33. PubMed ID: 19718067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of intercurrent EBV infection on ATP levels in CD4+ T cells of pediatric kidney transplant recipients.
    Ben-Youssef R; Baron PW; Sahney S; Weissman J; Baqai W; Franco E; Kore A; Trimzi M; Ojogho O
    Pediatr Transplant; 2009 Nov; 13(7):851-5. PubMed ID: 19017293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards minimizing immunosuppression in pediatric liver transplant recipients.
    Turmelle YP; Nadler ML; Anderson CD; Doyle MB; Lowell JA; Shepherd RW
    Pediatr Transplant; 2009 Aug; 13(5):553-9. PubMed ID: 19067920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay.
    Cadillo-Chávez R; de Echegaray S; Santiago-Delpín EA; Rodríguez-Trinidad AT; Camacho-Carrazo B; Alfaro T; Saavedra-Pozo M; Carrasquillo L; González-Caraballo ZA; Morales-Otero LA
    Transplant Proc; 2006 Apr; 38(3):918-20. PubMed ID: 16647510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients.
    Gras J; Wieërs G; Vaerman JL; Truong DQ; Sokal E; Otte JB; Délépaut B; Cornet A; de Ville de Goyet J; Latinne D; Reding R
    Liver Transpl; 2007 Mar; 13(3):426-33. PubMed ID: 17318867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection.
    Sánchez-Velasco P; Rodrigo E; Valero R; Ruiz JC; Fernández-Fresnedo G; López-Hoyos M; Piñera C; Palomar R; Leyva-Cobián F; Arias M
    Clin Transplant; 2008; 22(1):55-60. PubMed ID: 18217906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell mediated immunity (CMI) and post transplant viral infections--role of a functional immune assay to titrate immunosuppression.
    Gautam A; Fischer SA; Yango AF; Gohh RY; Morrissey PE; Monaco AP
    Int Immunopharmacol; 2006 Dec; 6(13-14):2023-6. PubMed ID: 17161357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing immunologic function through CD4 T-lymphocyte ahenosine triphosphate levels by ImmuKnow assay in Chinese patients following renal transplantation.
    Zhou H; Wu Z; Ma L; Wu W; Yang S; Wang Q; Yuan X; Wu L; Lin X; Tan J
    Transplant Proc; 2011 Sep; 43(7):2574-8. PubMed ID: 21911125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder.
    Gautam A; Morrissey PE; Brem AS; Fischer SA; Gohh RY; Yango AF; Monaco AP
    Pediatr Transplant; 2006 Aug; 10(5):613-6. PubMed ID: 16856999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry.
    Ng VL; Fecteau A; Shepherd R; Magee J; Bucuvalas J; Alonso E; McDiarmid S; Cohen G; Anand R;
    Pediatrics; 2008 Dec; 122(6):e1128-35. PubMed ID: 19047213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.